PureTech Health Affiliate Reports Positive Results In Alopecia Study

Thu, 19th Dec 2019 17:33

(Alliance News) - Pure Tech Health PLC on Thursday said its affiliate Follica announced topline results from its optimisation study to treat hair loss in male androgenetic alopecia.

The study was designed to select the optimal treatment regimen using Follica's proprietary device in combination with a topical drug and successfully met its primary endpoint, PureTech said.

PureTech holds a near 80% stake in Follica.

The stock closed up 5.6% at 285.00 pence, among the best performers in the FTSE 250 on Thursday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Related Shares

More News

29 May 2024 21:30

IN BRIEF: PureTech's Ankili to be acquired by Virtual Therapeutics

PureTech Health PLC - London-listed Biotech company headquartered in Boston - Says Tuesday that founded entity, Ankili Inc, a game developer focusing ...

21 May 2024 14:07

PureTech-founded Vedanta begins trials for VE303 colonic bacteria drug

(Alliance News) - PureTech Health PLC on Tuesday said that a company it founded and in which it maintains a stake had begun trials of a new treatment ...

20 May 2024 10:13

PureTech Health launches $100m tender offer

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health launched a proposed $100m tender offer on Monday, aiming to repurchase share...

20 May 2024 09:03

IN BRIEF: PureTech Health launches USD100 million buyback programme

PureTech Health PLC - London-based biotherapeutics company - Launches tender offer to repurchase shares for a maximum consideration of USD100 million....

10 May 2024 16:39

EARNINGS AND TRADING: Asiamet Resources declares special dividend

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Latest Share Chat